Patents by Inventor KEDERNATH SASTRY

KEDERNATH SASTRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME
    Publication number: 20200399379
    Abstract: The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Inventors: NAGARAJ GOVINDAPPA, MARIA MELINA SOARES, KEDERNATH SASTRY
  • Fusion immunomodulatory proteins and methods for making same
    Patent number: 10766963
    Abstract: The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: September 8, 2020
    Inventors: Nagaraj Govindappa, Maria Melina Soares, Kedernath Sastry
  • FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME
    Publication number: 20180251560
    Abstract: The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
    Type: Application
    Filed: May 1, 2018
    Publication date: September 6, 2018
    Inventors: NAGARAJ GOVINDAPPA, MARIA MELINA SOARES, KEDERNATH SASTRY
  • Fusion immunomodulatory proteins and methods for making same
    Patent number: 9988456
    Abstract: The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: June 5, 2018
    Assignee: BIOCON LIMITED
    Inventors: Nagaraj Govindappa, Maria Melina Soares, Kedernath Sastry
  • FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME
    Publication number: 20160009807
    Abstract: The present invention relates generally to the field of generating recombinant chimeric fusion proteins to be used in the cancer therapy, and more specifically, to fusion molecules of Anti-EGFR1-TGF?RII, Anti-EGFR1-PD1 and Anti-CTLA4-PD1 and methods of generating same, wherein the methods reduce production costs and increase homogeneity of the recombinant chimeric fusion proteins.
    Type: Application
    Filed: March 10, 2014
    Publication date: January 14, 2016
    Inventors: NAGARAJ GOVINDAPPA, MARIA MELINA SOARES, KEDERNATH SASTRY